Overall Status

Completed (16)

Recruiting (4)

Terminated (3)

Unknown status (2)

Active, not recruiting (1)

Enrolling by invitation (1)

Phase

n/a (8)

phase 3 (6)

phase 1 (2)

phase 2 (2)

phase 4 (2)

Collaborator

Allergan (2)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (1)

Ipsen (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

National Institute on Aging (NIA) (1)

University of Oslo School of Pharmacy (1)

Study Documents

Intervention Type

drug (13)

device (5)

diagnostic test (3)

other (3)

biological (2)

procedure (2)

behavioral (1)

radiation (1)

Funder Type

Other (17)

Industry (10)

Study Type

Interventional (20)

Observational (7)

Muscular Diseases

Showing 26 - 27 of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Muscular Diseases Trial in Oslo (atorvastatin)

Completed

Muscular Diseases

atorvastatin

Oslo, Norway

Lipidklinikken, Rikshospitalet-Radiumhospitalet HF

May 9, 2012

Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases Trial in Hartford, Storrs, Amherst (Atorvastatin, Placebo)

Completed

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscular Diseases

Atorvastatin
Placebo

Hartford, Connecticut
+2 more

Jan 5, 2012